Citation Impact
Citing Papers
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
High burden and pervasive positive selection of somatic mutations in normal human skin
2015 StandoutScience
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens
1987 StandoutNature
Mutations induced by ultraviolet light
2005
Cancer burden in the year 2000. The global picture
2001 Standout
UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer
2011
Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1)
1987 Standout
Global Cancer Statistics, 2002
2005 Standout
Epidemiology of melanoma
2000
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
Interaction between the CD45 antigen and phytohemagglutinin. Inhibitory effect on the lectininduced T cell proliferation by anti‐CD45 monoclonal antibody
1987
Esophageal Cancer
2003 Standout
Most CD4+ T cells from human immunodeficiency virus-1 infected patients can undergo prolonged clonal expansion.
1989 StandoutNobel
CD4: Collaborator in immune recognition and HIV infection
1990 StandoutNobel
Analysis of Diffrentiation and Transformation of Cells by Lectins
1988
Distinct Sets of Genetic Alterations in Melanoma
2005 Standout
T-cell antigen receptor genes and T-cell recognition
1988 StandoutNature
HIV infection does not require endocytosis of its receptor, CD4
1988 StandoutNobel
Head and Neck Cancer
1993 Standout
Thymic selection in CD8 transgenic mice supports an instructive model for commitment to a CD4 or CD8 lineage
1991 StandoutNobel
Prognostic value of ebv markers in the clinical management of nasopharyngeal carcinoma (NPC): A multicenter follow‐up study
1988
T cell receptor antagonist peptides induce positive selection
1994 Standout
A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States)
2001
Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 Å resolution
1992 StandoutNobel
Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class ii isotypes
1989
A Monoclonal Antibody 7G7/B6, Binds to an Epitope on the Human Interleukin-2 (IL-2) Receptor That is Distinct From That Recognized by IL-2 or Anti-Tac
1985
Rat Monoclonal Antibodies to Mouse IgG1, IgG2a, IgG2b, and IgG3 Subclasses, and Kappa Chain Isotypic Determinants
1984
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
1998 Standout
Integrins: A family of cell surface receptors
1987 Standout
Engineered secreted T-cell receptor alpha beta heterodimers.
1991
Surface Structures Involved in Target Recognition by Human Cytotoxic T Lymphocytes
1982 Science
CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells.
1988 StandoutNobel
Arginine 45 is a major part of the antigenic determinant of human beta 2-microglobulin recognized by mouse monoclonal antibody BBM.1.
1983
The Staphylococcal Enterotoxins and Their Relatives
1990 StandoutScience
A Class I Antigen, HLA-G, Expressed in Human Trophoblasts
1990 StandoutScience
Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain.
1993
Expression and function of transplantation antigens with altered or deleted cytoplasmic domains
1983
Cloning, sequence and expression of human interleukin-2 receptor
1984 Nature
The CD8+ Dendritic Cell Subset Selectively Endocytoses Dying Cells in Culture and In Vivo
2002 StandoutNobel
T-cell-replacing factor (interleukin 5) induces expression of interleukin 2 receptors on murine splenic B cells.
1987
Expression of CD4 in transgenic mice alters the specificity of CD8 cells for allogeneic major histocompatibility complex.
1991 StandoutNobel
The Development, Maturation, and Turnover Rate of Mouse Spleen Dendritic Cell Populations
2000
Patterns of gene expression and the cellular origins of human leukaemias
1978
Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies
1983
Phosphorylation of the human interleukin-2 receptor and a synthetic peptide identical to its C-terminal, cytoplasmic domain.
1986
Reconstitution of MHC class I specificity by transfer of the T cell receptor and Lyt-2 genes
1987
A rat anti-mouse kappa chain specific monoclonal antibody, 187.1.10: Purification, immunochemical properties and its utility as a general second-antibody reagent
1984
Lymphoid Cell Surface Interaction Structures Detected Using Cytolysis‐Inhibiting Monoclonal Antibodies
1982
Anomalous phenotype in thymic acute lymphoblastic leukaemia
1980 StandoutNatureNobel
High Pathogenic Potential of Low-Affinity Autoantibodies in Experimental Autoimmune Hemolytic Anemia
1999 StandoutNobel
Clonal Deletion Versus Clonal Anergy: The Role of the Thymus in Inducing Self Tolerance
1990 StandoutScienceNobel
Molecular cloning and structure of the human interleukin 2 receptor gene
1985 StandoutNobel
Demonstration of epstein‐barr virus‐associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies
1974
The beta 1 domain of the mouse E beta chain is important for restricted antigen presentation to helper T-cell hybridomas.
1985 StandoutNobel
Antigenic stimulation regulates the level of expression of interleukin 2 receptor on human T cells.
1984
Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.
1983
The Linkage of Innate to Adaptive Immunity via Maturing Dendritic Cells In Vivo Requires CD40 Ligation in Addition to Antigen Presentation and CD80/86 Costimulation
2004 StandoutNobel
Molecular basis for two different affinity states of the interleukin 2 receptor: affinity conversion model.
1986 StandoutNobel
Nucleotide sequence of mouse IL-2 receptor cDNA and its comparison with the human IL-2 receptor sequence
1985 StandoutNobel
Brefeldin A, a drug that blocks secretion, prevents the assembly of non-clathrin-coated buds on Golgi cisternae
1991 StandoutNobel
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Phenotypic analysis of the inflammatory exudate in murine lymphocytic choriomeningitis.
1987 StandoutNobel
Studies and Perspectives of Protein Kinase C
1986 StandoutScience
Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance
2002 StandoutNobel
Normal Development of Mice Deficient in β 2 M, MCClass I Proteins, and CD8 + T Cells
1990 StandoutScienceNobel
Nasopharyngeal carcinoma. X. Presence of Epstein‐Barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya
1975 StandoutNobel
Expression of functional human interleukin-2 receptor in mouse T cells by cDNA transfection
1986 StandoutNatureNobel
In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination
2004 StandoutNobel
Characterization of high-affinity receptors for interleukin 5 on interleukin 5-dependent cell lines.
1989 StandoutNobel
Biochemical evidence for a third chain of the interleukin-2 receptor.
1991 StandoutNobel
Influenza Virus–induced Dendritic Cell Maturation Is Associated with the Induction of Strong T Cell Immunity to a Coadministered, Normally Nonimmunogenic Protein
2003 StandoutNobel
Induction of expression and phosphorylation of the human interleukin 2 receptor by a phorbol diester.
1984
The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: Identification of constant and variable peptides
1983 StandoutNobel
Nasopharyngeal carcinoma. IV. Evolution of complement‐fixing antibodies during the course of the disease
1973
Distinct Reactivities of Four Monoclonal Antibodies with Human Interleukin 2 Receptor
1985
The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains
1984 StandoutNatureNobel
Phenotypic and functional properties of murine thymocytes. I. Precursors of cytolytic T lymphocytes and interleukin 2-producing cells are all contained within a subpopulation of "mature" thymocytes as analyzed by monoclonal antibodies and flow microfluorometry
1982
Biochemical characterization of VLA-1 and VLA-2. Cell surface heterodimers on activated T cells.
1985
Gene transfer of H-2 class II genes: Antigen presentation by mouse fibroblast and hamster B-cell lines
1984
Molecular cloning of cDNA encoding human interleukin-2 receptor
1984 StandoutNatureNobel
CD1 Recognition by Mouse NK1 + T Lymphocytes
1995 StandoutScience
Interleukin-2: Inception, Impact, and Implications
1988 StandoutScience
Works of A. Liabeuf being referenced
Time trends in oesophageal cancer incidence in Côte d’Or (France), 1976-93
1997
Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: An eortc multicenter case‐control study in Belgium, France and Germany
1994
Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis‐inhibiting effect of 7 monoclonal antibodies
1982
Cytotoxic and fluorescent assays for thymocyte subpopulations differing in surface thy-1 level
1979
SHORT COMMUNICATION: MOUSE MONOCLONAL ANTIBODY AGAINST Lyt ‐ 1.1 ALLOANTIGEN *
1981
Nasopharyngeal carcinoma (NPC). VI. Presence of an EBV nuclear antigen in fresh tumour biopsies. Preliminary results.
1973
Cytotoxic antibodies to human leukaemia cells in normal human sera.
1976
Melanoma and use of sunscreens: An EORTC case‐control study in germany, belgium and france
1995
An antigenic determinant of human beta 2-microglobulin masked by the association with HLA heavy chains at the cell surface: analysis using monoclonal antibodies.
1981
A 55,000 Mr surface antigen on activated human T lymphocytes defined by a monoclonal antibody
1983